Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study - Top-Institutions - MDSpire

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study

  • By

  • Ugo Falagario

  • Ivan Jambor

  • Pekka Taimen

  • Kari T. Syvänen

  • Esa Kähkönen

  • Harri Merisaari

  • Ileana Montoya Perez

  • Juha Knaapila

  • Aida Steiner

  • Janne Verho

  • Ashutosh Tewari

  • Hannu J. Aronen

  • Giuseppe Carrieri

  • Peter J. Boström

  • Otto Ettala

  • August 10, 2020

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urology
    • Radiology
    • Oncology

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urology
    • Radiology

  • #3

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Oncology
    • Radiology
    • Urology

  • #4

    University of Toronto, Sunnybrook Health Sciences Centre
    University of Toronto, Sunnybrook Health Sciences Centre

    Toronto, ON

    Key Differentiators

    • Urology
    • Radiology

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Urology
    • Radiology

Original Source(s)

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study

  • by Ugo Falagario, Ivan Jambor, Pekka Taimen, Kari T. Syvänen, Esa Kähkönen, Harri Merisaari, Ileana Montoya Perez, Juha Knaapila, Aida Steiner, Janne Verho, Ashutosh Tewari, Hannu J. Aronen, Giuseppe Carrieri, Peter J. Boström, Otto Ettala

  • August 10, 2020

Related Content

Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies

Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study